GGrantIndex
Sort

27,075 grants matching cholesterol

EHD1-mediated Inflammation and Resolution in Atherosclerosis

$720,774
Bishuang Cai · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · HL

Our Year of Healthy Living: A social marketing intervention for child care & home

$720,759
Dianne Stanton Ward · Univ Of North Carolina Chapel Hill · R01 · FY2015 · HL

Genetic Determinants of HDL-Cholesterol

$720,669
M. Ilyas Kamboh · University Of Pittsburgh At Pittsburgh · R01 · FY2009 · HL

Preventing Childhood Obesity Through a Mindfulness-based Parent Stress Intervention

$720,630
Rajita Sinha · Yale University · R01 · FY2020 · DK

Gene-Specific Responses to Exercise in Discordant Twins

$720,595
University Of Calif-Lawrenc Berkeley Lab · R01 · FY2004 · HL

Thromboregulation in Occlusive Vascular Diseases

$720,525
Aaron J. Marcus · Weill Medical Coll Of Cornell Univ · R01 · FY2012 · HL

APOE Genotype and Sequelae of Infant Cardiac Surgery

$720,478
Childrens Hospital Of Philadelphia · R01 · FY2004 · HL

Atheroprotective Gene Therapy

$720,435
David A Dichek · University Of Washington · R01 · FY2022 · HL

Atheroprotective Gene Therapy

$720,435
David A Dichek · University Of Washington · R01 · FY2021 · HL

Atheroprotective Gene Therapy

$720,435
David A Dichek · University Of Washington · R01 · FY2020 · HL

Mechanism and inhibition of SREBP-dependent cholesterol/lipid metabolism

$720,423
Gerhard Wagner · Harvard Medical School · R01 · FY2014 · HL

Randomized Trial of CVD Education and Problem-Solving Training in Urban Diabetics

$720,189
Felicia Hill-Briggs · Johns Hopkins University · R01 · FY2010 · HL

MODELING DNA DIVERSITY IN CARDIOVASCULAR HEALTH/DISEASE

$719,971
University Of Washington · R01 · FY2000 · HL

Control of vesicular trafficking in the hepatocyte.

$719,937
Allan W Wolkoff · Albert Einstein College Of Medicine · R01 · FY2014 · DK

APEX: ADIPOSITY PREVENTION BY EXERCISE IN BLACK GIRLS

$719,931
Medical College Of Georgia (Mcg) · R01 · FY2003 · HL

Biomarkers of ABCA1 mediated functions in Alzheimers disease

$719,642
Hussein N Yassine · University Of Southern California · R01 · FY2021 · AG

Expanding the reach of the Nutritious Eating with Soul (NEW Soul) program: A Type 2 hybrid effectiveness-implementation trial

$719,517
Gabrielle Michelle Turner-McGrievy · University Of South Carolina At Columbia · R01 · FY2025 · HL

OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP).

$719,495
Carolyn Harmon Still · Case Western Reserve University · R01 · FY2021 · NR

Brain Single-nuclei and iPS-derived cells transcriptomic analysis to define the contribution of neuronal and glial pathw

$719,094
Oscar Harari · Washington University · R56 · FY2021 · AG

Low CV Risk, Ages 25-44 & CV/non-CV Outcomes, Ages 65+

$718,993
Martha L Daviglus · Northwestern University At Chicago · R01 · FY2007 · HL

Bacterial metabolites controlling Th17 and Treg cells

$718,734
Jun R. Huh · Harvard Medical School · R01 · FY2021 · DK

Engineering protease-resistant antiviral peptide inhibitors for SARS-CoV-2

$718,692
Anne Moscona · Columbia University Health Sciences · R01 · FY2023 · AI

Technology-Supported Treatment of Sleep Apnea in Prediabetes

$718,634
Esra Tasali · University Of Chicago · R01 · FY2021 · DK

Translating COPD Guidelines inot Primary Care Practice

$718,575
Donna R Parker · Memorial Hospital Of Rhode Island · R01 · FY2010 · HL

Individualized Risk Stratification Using the Genomic Contribution

$718,570
Gary Wayne Beecham · University Of Miami School Of Medicine · R01 · FY2014 · HL